Avego
Finance · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1 Penn Plz Ste 1620, New York, New York,...Phone Number
(646) 844-0030Website
www.avego.comRevenue
<$5 MillionIndustry
About Avego
Avego is a multi-strategy investment firm dedicated to the healthcare sector, aiming to combine industry expertise and capital with entrepreneurial management to enhance patient outcomes. The firm invests in both private and public companies innovating in healthcare, providing growth capital and focusing on mid-to-late stage venture opportunities. Commitment to integrity, success alignment, and perseverance defines their value system, as they leverage their operating experience to drive growth in their portfolio companies. Avego seeks to create a trusted partnership environment that fosters high standards of accountability and progression in the healthcare landscape.Explore more
Avego Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Avego
Compare insights from companies similar to Avego, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Avego Tech Stack
A closer look at the technologies used by Avego
See more technologies
Top Finance Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Avego
Sign Up For FreeTo access detailed company insights
Avego is a multi-strategy investment firm dedicated to the healthcare sector, aiming to combine industry expertise and capital with entrepreneurial management to enhance patient outcomes. The firm invests in both private and public companies innovating in healthcare, providing growth capital and focusing on mid-to-late stage venture opportunities.... Read More
